416 related articles for article (PubMed ID: 31036068)
1. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models.
Martinez-Velez N; Marigil M; García-Moure M; Gonzalez-Huarriz M; Aristu JJ; Ramos-García LI; Tejada S; Díez-Valle R; Patiño-García A; Becher OJ; Gomez-Manzano C; Fueyo J; Alonso MM
Acta Neuropathol Commun; 2019 Apr; 7(1):64. PubMed ID: 31036068
[TBL] [Abstract][Full Text] [Related]
2. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.
Martínez-Vélez N; Garcia-Moure M; Marigil M; González-Huarriz M; Puigdelloses M; Gallego Pérez-Larraya J; Zalacaín M; Marrodán L; Varela-Guruceaga M; Laspidea V; Aristu JJ; Ramos LI; Tejada-Solís S; Díez-Valle R; Jones C; Mackay A; Martínez-Climent JA; García-Barchino MJ; Raabe E; Monje M; Becher OJ; Junier MP; El-Habr EA; Chneiweiss H; Aldave G; Jiang H; Fueyo J; Patiño-García A; Gomez-Manzano C; Alonso MM
Nat Commun; 2019 May; 10(1):2235. PubMed ID: 31138805
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virotherapy for the treatment of pediatric brainstem gliomas.
Gállego Pérez-Larraya J; García-Moure M; Alonso MM
Rev Neurol (Paris); 2023 Jun; 179(5):475-480. PubMed ID: 37061388
[TBL] [Abstract][Full Text] [Related]
4. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas.
Laspidea V; Puigdelloses M; Labiano S; Marrodán L; Garcia-Moure M; Zalacain M; Gonzalez-Huarriz M; Martínez-Vélez N; Ausejo-Mauleon I; de la Nava D; Herrador-Cañete G; Marco-Sanz J; Guruceaga E; de Andrea CE; Villalba M; Becher O; Squatrito M; Matía V; Gállego Pérez-Larraya J; Patiño-García A; Gupta S; Gomez-Manzano C; Fueyo J; Alonso MM
JCI Insight; 2022 Apr; 7(7):. PubMed ID: 35393952
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
Gállego Pérez-Larraya J; Garcia-Moure M; Labiano S; Patiño-García A; Dobbs J; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; Puigdelloses M; Laspidea V; Astigarraga I; Lopez-Ibor B; Cruz O; Oscoz Lizarbe M; Hervas-Stubbs S; Alkorta-Aranburu G; Tamayo I; Tavira B; Hernandez-Alcoceba R; Jones C; Dharmadhikari G; Ruiz-Moreno C; Stunnenberg H; Hulleman E; van der Lugt J; Idoate MÁ; Diez-Valle R; Esparragosa Vázquez I; Villalba M; de Andrea C; Núñez-Córdoba JM; Ewald B; Robbins J; Fueyo J; Gomez-Manzano C; Lang FF; Tejada S; Alonso MM
N Engl J Med; 2022 Jun; 386(26):2471-2481. PubMed ID: 35767439
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.
Chastkofsky MI; Pituch KC; Katagi H; Zannikou M; Ilut L; Xiao T; Han Y; Sonabend AM; Curiel DT; Bonner ER; Nazarian J; Horbinski CM; James CD; Saratsis AM; Hashizume R; Lesniak MS; Balyasnikova IV
Clin Cancer Res; 2021 Mar; 27(6):1766-1777. PubMed ID: 33272983
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma.
Lamfers ML; Idema S; Bosscher L; Heukelom S; Moeniralm S; van der Meulen-Muileman IH; Overmeer RM; van der Valk P; van Beusechem VW; Gerritsen WR; Vandertop WP; Dirven CM
Clin Cancer Res; 2007 Dec; 13(24):7451-8. PubMed ID: 18094429
[TBL] [Abstract][Full Text] [Related]
9. Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.
Pal S; Kozono D; Yang X; Fendler W; Fitts W; Ni J; Alberta JA; Zhao J; Liu KX; Bian J; Truffaux N; Weiss WA; Resnick AC; Bandopadhayay P; Ligon KL; DuBois SG; Mueller S; Chowdhury D; Haas-Kogan DA
Cancer Res; 2018 Jul; 78(14):4007-4021. PubMed ID: 29760046
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for paediatric brainstem gliomas.
Khan DA; Laghari AA; Bari ME; Shamim MS
J Pak Med Assoc; 2019 Sep; 69(9):1400-1402. PubMed ID: 31511736
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
[TBL] [Abstract][Full Text] [Related]
13. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death.
Alonso MM; Jiang H; Yokoyama T; Xu J; Bekele NB; Lang FF; Kondo S; Gomez-Manzano C; Fueyo J
Mol Ther; 2008 Mar; 16(3):487-93. PubMed ID: 18253154
[TBL] [Abstract][Full Text] [Related]
14. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.
de la Nava D; Ausejo-Mauleon I; Laspidea V; Gonzalez-Huarriz M; Lacalle A; Casares N; Zalacain M; Marrodan L; García-Moure M; Ochoa MC; Tallon-Cobos AC; Hernandez-Osuna R; Marco-Sanz J; Dhandapani L; Hervás-Corpión I; Becher OJ; Nazarian J; Mueller S; Phoenix TN; van der Lugt J; Hernaez M; Guruceaga E; Koschmann C; Venneti S; Allen JE; Dun MD; Fueyo J; Gomez-Manzano C; Gállego Pérez-Larraya J; Patiño-García A; Labiano S; Alonso MM
Neuro Oncol; 2024 Mar; ():. PubMed ID: 38554031
[TBL] [Abstract][Full Text] [Related]
15. Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.
Tejada S; Alonso M; Patiño A; Fueyo J; Gomez-Manzano C; Diez-Valle R
Neurosurgery; 2018 Nov; 83(5):1050-1056. PubMed ID: 29088386
[TBL] [Abstract][Full Text] [Related]
16. Pediatric diffuse intrinsic pontine glioma: where do we stand?
Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.
Shi S; Lu S; Jing X; Liao J; Li Q
World Neurosurg; 2021 Apr; 148():e565-e571. PubMed ID: 33476781
[TBL] [Abstract][Full Text] [Related]
18. Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas.
Dalle Ore C; Coleman C; Gupta N; Mueller S
Pediatr Neurosurg; 2023; 58(5):259-266. PubMed ID: 36642062
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
[TBL] [Abstract][Full Text] [Related]
20. Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity.
Schuelke MR; Wongthida P; Thompson J; Kottke T; Driscoll CB; Huff AL; Shim KG; Coffey M; Pulido J; Evgin L; Vile RG
J Immunother Cancer; 2019 Jul; 7(1):188. PubMed ID: 31315671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
